Sun-Ranbaxy:-
Generic drugs maker Sun Pharma’s
merger with ailing Ranbaxy has hit the roadblock as the company has
not received the approval from Competition Commission of India(CCI).
The competition regulator was supposed to come out with its decision
by end of November and it is learnt that the regulator still has not
given its nod to the $4 billion merger.Regulatory approval from
India’s CCI and America’s Federal Trade Commission (FTC) are yet
to be received for the biggest merger and acquisition dealin pharma
sector in Asia Pacific region this year.
Maruti Suzki :-
Maruti Suzuki, India's largest
car maker, said it would recall nearly 3,800 units of Ciaz to check a
suspected fault in the vehicle's clutch operation system. Launched in
October this year, Ciaz the mid-sized sedan competing against the
segment best-seller Honda City had received a healthy response from
the customers which pushed it to the second spot beating Hyundai's
Verna. The Ciaz recall, which can potentially cause inconvenience to
its owners, comes just two months after the car market leader
announced a recall of 69,555 units of Dzire, Swift and Ritz in
September to repair a wiring harness fitment.
